Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Sekisui XenoTech now offers human liver tissue microarrays and a microsomal pool for studying and developing new treatments for fatty liver disease.
read more
Avara Pharmaceutical announced the acquisition of the GlaxoSmithKline consumer healthcare manufacturing facility in Aiken, South Carolina is complete.
read more
Novartis is suing Regeneron for patent infringement over the manufacturing process used to produce its Eylea and Zaltrap eye treatments.
read more
Allied Patients has launched to develop affordable generic medications and do right by patients.
read more
Evotec has launched its accelerated drug development service INDiGO.
read more
Accelovance has signed a merger agreement with Linical, a CRO based in Asia in the fields of oncology, immunology, and neurology.
read more
Dr. Reddy’s and its subsidiary, Promius Pharma announced the filing of NDA for its migraine candidate DFN-02 with the FDA.
read more
AGC Biologics announced the addition of a new building complex that will house the company’s global headquarters in Bothell, Washington.
read more
Ligand Pharmaceuticals has entered into an agreement with venBio Partners which permits venBio’s portfolio companies to enter into a pre-agreed worldwide OmniAb platform license agreement.
read more
Following a 15-year career with the company, Abhijit Mukherjee, Chief Operating Officer, will retire on March 31, 2018.
read more
Therapure Biopharma has launched its plasma products and technology division as Evolve Biologics, a developer of plasma-derived therapeutics, led by an experienced senior management team.
read more
Stellar Biotechnologies initiated the second phase of an expansion project at the Port of Hueneme, north of Los Angeles.
read more
SSCI has implemented Mettler Toledo’s thermal analysis instruments that meet the updated regulatory data integrity standards, which are now being enforced by regulatory agencies in the United States and European Union as of Jan. 1, 2018.
read more
Wednesday, March 28, 2018
Rentschler Biopharma SE announced Dr. Thomas Rösch will join the company as Vice President Biopharma Engineering & Technology, effective April 1, 2018.
read more
Wednesday, March 28, 2018
MedPharm announced a multi-million dollar investment by Ampersand Capital Partners.
read more